免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

PubMed

Impact1: Supporting Innovation in Pediatric and Maternal Health-5 Years of Outcomes.

PMID: 42106561 ·

E, l, i, s, a, b, e, t, , R, o, s, à, s, , C, a, n, y, e, l, l, e, s, ;, , J, u, l, i, a, n, a, , P, e, r, l, ;, , M, a, r, t, a, , A, r, e, n, a, s, -, J, a, l, ;, , A, n, t, j, e, , K, i, r, s, c, h, n, e, r, ;, , I, g, n, a, c, i, o, , A, n, d, r, é, s, , P, é, r, e, z, , R, o, m, e, r, o, ;, , M, o, h, i, t, , S, i, n, g, h, a, l, a, ;, , M, a, n, i, k, a, n, t, a, m, , G, a, d, d, a, m, ;, , A, n, u, r, a, d, h, a, , D, a, y, a, l, ;, , Y, a, i, r, , J, , B, l, u, m, e, n, f, e, l, d, ;, , J, a, m, e, s, , K, , W, a, l, l, ;, , K, u, n, j, , S, h, e, t, h, ;, , J, a, n, e, n, e, , H, , F, u, e, r, c, h

学術誌Annals of biomedical engineering
年
PMID42106561

抄録

Impact1 at the Stanford Mussallem Center for Biodesign was established in 2019 through its core partnership with UCSF as an FDA-funded Pediatric Device Consortium. We hypothesized that providing innovators in pediatric and maternal healthcare with mentorship, connections to experts, and grant funding would promote development, validation, approval, and commercialization of safe and effective health technologies for pediatric and maternal patients, and lead to positive broader impacts, measured a

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。

↑